The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia ...

New research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational ...

Researchers sought to determine whether adding selinexor to chemotherapeutic induction and consolidation regimen would improve outcomes in AML.

So now, you know, we have competing standards of care in the frontline for AML, which is either high intensity induction or ...

Acute myelogenous leukemia (AML), also known as acute myeloid leukemia, is a type of cancer that starts in your bone marrow (the soft, spongy tissue inside the bones that makes blood cells). AML is ...

I think probably the best one is the urban patient who has access to an academic medical center that is running clinical ...